News
Scientists issue call to arms over antifungal resistance
Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.
R&D
Parkinson’s disease: Transitioning from symptom control to d...
The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.
News
Parkinson's charity partners Biognosys on biomarker project
A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.
News
Amazon launches its AI drug discovery platform
Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.
R&D
From genetic insight to Phase 3: What rare neurology require...
Rare neurology is not defined by a lack of scientific opportunity or capital.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
